Cognoa is a healthcare technology company focused on developing digital diagnostic and therapeutic solutions for children and families. Their mission centers on enabling early interventions for developmental conditions, particularly autism, through innovative software products. The company's flagship product, Canvas Dx, is the first FDA-authorized digital diagnostic aid for autism, designed to facilitate rapid and equitable diagnosis.
Cognoa's approach aims to address the critical issue of delayed diagnosis in developmental conditions, which often occurs years after the optimal intervention window. By leveraging digital technologies, Cognoa strives to optimize healthcare resources, save time in the diagnostic process, and ultimately improve outcomes for children and families worldwide. Their work represents a significant step forward in making early diagnosis and intervention more accessible and efficient.
